NCT05653011 Predictors of Prognosis in IBD Patients
| NCT ID | NCT05653011 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Bundang Hospital |
| Condition | Inflammatory Bowel Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2013-03-11 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2013-03-11 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A study of clinical characteristics and potential prognostic factors in inflammatory bowel disease
Eligibility Criteria
Inclusion Criteria: * control group: Patients who do not have colitis, cancer, and advanced polyp (the number of polyps ≥ 3, the size of polyps ≥ 1cm, high-grade adenoma, villous adenoma) * TNF-α inhibitor-naive IBD group: IBD patients who do not have a history of TNF-α inhibitor treatment * TNF-α inhibitor-treated IBD group: IBD patients who are treated with TNF-α inhibitor Exclusion Criteria: * Age under 18 years * Patients who were treated with antibiotics or probiotics within the last 3 months
Contact & Investigator
Nayoung Kim, M.D., Ph.D
STUDY CHAIR
Seoul National University Bundang Hospital
Frequently Asked Questions
Who can join the NCT05653011 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inflammatory Bowel Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05653011 currently recruiting?
Yes, NCT05653011 is actively recruiting participants. Contact the research team at juk0220@nate.com for enrollment information.
Where is the NCT05653011 trial being conducted?
This trial is being conducted at Seongnam-si, South Korea.
Who is sponsoring the NCT05653011 clinical trial?
NCT05653011 is sponsored by Seoul National University Bundang Hospital. The principal investigator is Nayoung Kim, M.D., Ph.D at Seoul National University Bundang Hospital. The trial plans to enroll 100 participants.